JESSICA HUBACH: Open Payments
NPI 1922715374 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 99 payments from 20 companies in 2025. Trend: 2023 $1,077 · 2024 $1,605 · 2025 $1,704
Food & beverage: $1,604Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 24 | $305 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $198 |
| ABBVIE INC. | 15 | $189 |
| Amgen Inc. | 10 | $158 |
| Janssen Biotech, Inc. | 5 | $103 |
| Kerecis Limited | 6 | $91 |
| Lilly USA, LLC | 5 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| PFIZER INC. | 4 | $73 |
| Integra LifeSciences Corporation | 3 | $65 |
Products named: Sotyktu, OTEZLA, SKYRIZI, TREMFYA, Kerecis SurgiClose, TALTZ, ILUMYA, DUPIXENT.
Industry payments across KS — which companies pay providers there.
